Publications

Browse our recent publications

AACR: Plasma Protein-Protein Interactome (PPI) Maps For Non-Small Cell Lung Cancer (NSCLC) Using The Proteograph Product Suite

AACR: Plasma Protein-Protein Interactome (PPI) Maps For Non-Small Cell Lung Cancer (NSCLC) Using The Proteograph Product Suite

This AACR 2020 poster demonstrates how the Proteograph platform can be used to identify PPI clusters that are differentiated between NSCLC and control individuals.
file_download DOWNLOAD

Apr
2020

Applications:
Cancer Research

Product: proteograph

AACR: Analytical validation of the Proteograph platform for rapid and deep proteomic profiling

AACR: Analytical validation of the Proteograph platform for rapid and deep proteomic profiling

This AACR 2020 poster demonstrates how Seer's proprietary nanoparticle technology can be optimized for unbiased, deep plasma proteome profiling.
file_download DOWNLOAD

Apr
2020

Applications:
Assay Method

AACR: Scalable plasma proteomics in early-stage non-small cell lung cancer

AACR: Scalable plasma proteomics in early-stage non-small cell lung cancer

This AACR 2020 poster demonstrates the utility of the Proteograph platform to deeply profile plasma proteins as novel biomarkers in healthy vs. early NSCLC
file_download DOWNLOAD

Apr
2020

Applications:
Cancer Research

Product: Proteograph

US HUPO: Deep, Unbiased Plasma Protein Profiling and Protein-Protein Interaction vs Fractionation

US HUPO: Deep, Unbiased Plasma Protein Profiling and Protein-Protein Interaction vs Fractionation

Compared to typical fractionation, the Proteograph platform has superior coverage, depth, precision, and accuracy in unbiased proteomic profiling.
file_download DOWNLOAD 

Mar
2020

Applications:
Assay Method

© 2023 Seer, Inc. All rights reserved.

This icon serves as a link to download the eSSENTIAL Accessibility assistive technology app for individuals with physical disabilities. It is featured as part of our commitment to diversity and inclusion.